Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ph+ Acute Lymphoblastic Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01883219
What this trial is testing

TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaStem Cell TransplantationMinimal Residual Disease
Nanfang Hospital, Southern Medical University 80
Testing effectiveness (Phase 2)Ended earlyNCT03523429
What this trial is testing

PETHEMA-BLIN-01/PET069014 (BLIN-01)

Who this might be right for
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
PETHEMA Foundation 11
Not applicableStudy completedNCT07644351
What this trial is testing

A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 37
Testing effectiveness (Phase 2)Study completedNCT05594784
What this trial is testing

Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALL

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 79
Large-scale testing (Phase 3)UnknownNCT03624530
What this trial is testing

Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-transplants

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaTyrosine Kinase InhibitorMinimal Residual Disease+1 more
Nanfang Hospital, Southern Medical University 82
Post-approval studies (Phase 4)UnknownNCT01491763
What this trial is testing

Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE

Who this might be right for
Acute Lymphoblastic Leukemia Ph Positive
PETHEMA Foundation 70
Not applicableLooking for participantsNCT07684131
What this trial is testing

EWALL-PH OBSERVARTORY 2022

Who this might be right for
Acute Lymphoblastic Leukemia
Versailles Hospital 100
Not applicableUnknownNCT05026229
What this trial is testing

Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-LymphomaPhiladelphia-Positive Acute Lymphoblastic LeukemiaALL, Adult
First Affiliated Hospital Xi'an Jiaotong University 60
Not applicableStudy completedNCT02783651
What this trial is testing

Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

Who this might be right for
Relapsed/Refractory Acute Lymphoblastic Leukemia
Amgen 212
Early research (Phase 1)Study completedNCT00351975
What this trial is testing

Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases

Who this might be right for
Accelerated Phase of DiseaseAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+17 more
National Cancer Institute (NCI) 56
Not applicableStudy completedNCT03647215
What this trial is testing

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Who this might be right for
Chronic Phase Chronic Myelogenous LeukemiaAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous Leukemia+1 more
Incyte Biosciences UK 427
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493408
What this trial is testing

Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Blastic Transformation of Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)+1 more
The University of Hong Kong
Testing effectiveness (Phase 2)Looking for participantsNCT07227584
What this trial is testing

ALL Backbone in AYAs

Who this might be right for
Acute Lymphoblastic LeukemiaPhiladelphia Chromosome-Negative Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia (ALL)+1 more
Dana-Farber Cancer Institute 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT05456698
What this trial is testing

Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction Chemotherapy

Who this might be right for
Acute Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 31
Early research (Phase 1)Ended earlyNCT02819804
What this trial is testing

Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1Recurrent Adult Acute Lymphoblastic LeukemiaRecurrent Childhood Acute Lymphoblastic Leukemia+2 more
Northwestern University 1
Testing effectiveness (Phase 2)Ended earlyNCT01028716
What this trial is testing

Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Biphenotypic LeukemiaAcute Erythroid Leukemia in RemissionAcute Leukemia in Remission+27 more
Fred Hutchinson Cancer Center 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT03512405
What this trial is testing

Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
CD19 PositivePhiladelphia Chromosome PositiveRecurrent Acute Lymphoblastic Leukemia+1 more
City of Hope Medical Center 36
Not applicableNot Yet RecruitingNCT06649422
What this trial is testing

Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study

Who this might be right for
Leukemia, Lymphocytic, Acute, Adult
Shandong University 36
Testing effectiveness (Phase 2)UnknownNCT04688983
What this trial is testing

Study in Adult Ph-positive ALL

Who this might be right for
Acute Lymphoblastic Leukemia, Adult
Cardiff University 180
Testing effectiveness (Phase 2)Ended earlyNCT03518112
What this trial is testing

Low-Intensity Chemotherapy and Blinatumomab in Treating Patients With Philadelphia Chromosome Negative Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome NegativeRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center 6
Next Page
45